Sustained transmission of the measles virus amid declining MMR vaccination coverage is driving elevated 2026 case counts, with the CDC reporting 2,465 confirmed U.S. cases as of August 6—already exceeding the full-year 2025 total of 2,289. Most cases remain outbreak-associated and occur in unvaccinated individuals, reflecting gaps in herd immunity below the 95% threshold needed to prevent endemic spread. Recent model runs and surveillance data indicate ongoing risk from imported cases seeding local clusters, particularly in communities with sub-90% coverage. Weekly CDC updates and any shifts in state-level vaccination mandates or outbreak containment efforts through year-end represent key variables that could alter final tallies before resolution.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,825,482 Vol.
$7,825,482 Vol.
31 dic 2026
↑4,5k
26%
↑3k
95%
↑3,5k
95%
↑4k
63%
↑5k
20%
↑7,5k
11%
↑10k
5%
↑12,5k
5%
$7,825,482 Vol.
$7,825,482 Vol.
31 dic 2026
↑4,5k
$20 Vol.
26%
↑3k
$89,428 Vol.
95%
↑3,5k
$13,330 Vol.
95%
↑4k
$218,095 Vol.
63%
↑5k
$229,577 Vol.
20%
↑7,5k
$184,996 Vol.
11%
↑10k
$6,514,353 Vol.
5%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained transmission of the measles virus amid declining MMR vaccination coverage is driving elevated 2026 case counts, with the CDC reporting 2,465 confirmed U.S. cases as of August 6—already exceeding the full-year 2025 total of 2,289. Most cases remain outbreak-associated and occur in unvaccinated individuals, reflecting gaps in herd immunity below the 95% threshold needed to prevent endemic spread. Recent model runs and surveillance data indicate ongoing risk from imported cases seeding local clusters, particularly in communities with sub-90% coverage. Weekly CDC updates and any shifts in state-level vaccination mandates or outbreak containment efforts through year-end represent key variables that could alter final tallies before resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Feb 16, 2026, 11:51 AM ET
Volume
$7,825,482Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained transmission of the measles virus amid declining MMR vaccination coverage is driving elevated 2026 case counts, with the CDC reporting 2,465 confirmed U.S. cases as of August 6—already exceeding the full-year 2025 total of 2,289. Most cases remain outbreak-associated and occur in unvaccinated individuals, reflecting gaps in herd immunity below the 95% threshold needed to prevent endemic spread. Recent model runs and surveillance data indicate ongoing risk from imported cases seeding local clusters, particularly in communities with sub-90% coverage. Weekly CDC updates and any shifts in state-level vaccination mandates or outbreak containment efforts through year-end represent key variables that could alter final tallies before resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,825,482Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...Sustained transmission of the measles virus amid declining MMR vaccination coverage is driving elevated 2026 case counts, with the CDC reporting 2,465 confirmed U.S. cases as of August 6—already exceeding the full-year 2025 total of 2,289. Most cases remain outbreak-associated and occur in unvaccinated individuals, reflecting gaps in herd immunity below the 95% threshold needed to prevent endemic spread. Recent model runs and surveillance data indicate ongoing risk from imported cases seeding local clusters, particularly in communities with sub-90% coverage. Weekly CDC updates and any shifts in state-level vaccination mandates or outbreak containment efforts through year-end represent key variables that could alter final tallies before resolution.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti